China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)
China · Delayed Price · Currency is CNY 16.71
0.00 (0.00%)
Jun 9, 2026, 3:00 PM CST
SHA:600062 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 17,258 | 18,885 | 20,323 | 18,992 | 18,276 | 13,948 | |
Market Cap Growth | -10.58% | -7.07% | 7.01% | 3.92% | 31.03% | 11.51% |
Enterprise Value | 16,758 | 18,474 | 19,024 | 16,381 | 16,124 | 11,180 |
Last Close Price | 16.71 | 18.29 | 19.31 | 17.80 | 16.83 | 12.08 |
PE Ratio | 10.65 | 11.47 | 12.49 | 11.37 | 15.49 | 14.91 |
Forward PE | 9.86 | 10.36 | 11.03 | 12.46 | 15.32 | 11.70 |
PS Ratio | 1.61 | 1.72 | 1.81 | 1.68 | 1.90 | 1.53 |
PB Ratio | 1.33 | 1.51 | 1.83 | 1.47 | 1.61 | 1.33 |
P/TBV Ratio | 1.87 | 2.17 | 2.61 | 1.99 | 2.29 | 1.76 |
P/FCF Ratio | 23.28 | 21.71 | 17.11 | 15.26 | 20.55 | 16.42 |
P/OCF Ratio | 12.85 | 12.68 | 11.14 | 10.22 | 12.91 | 10.40 |
PEG Ratio | - | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 |
EV/Sales Ratio | 1.56 | 1.68 | 1.70 | 1.45 | 1.68 | 1.23 |
EV/EBITDA Ratio | 6.79 | 7.51 | 8.03 | 6.85 | 9.07 | 7.55 |
EV/EBIT Ratio | 9.95 | 10.83 | 11.59 | 9.49 | 13.03 | 10.81 |
EV/FCF Ratio | 22.60 | 21.24 | 16.02 | 13.16 | 18.13 | 13.16 |
Debt / Equity Ratio | 0.13 | 0.10 | 0.11 | 0.03 | 0.03 | 0.01 |
Debt / EBITDA Ratio | 0.69 | 0.49 | 0.51 | 0.13 | 0.16 | 0.04 |
Debt / FCF Ratio | 2.28 | 1.39 | 1.04 | 0.26 | 0.33 | 0.07 |
Net Debt / Equity Ratio | -0.11 | -0.10 | -0.14 | -0.24 | -0.22 | -0.34 |
Net Debt / EBITDA Ratio | -0.57 | -0.49 | -0.68 | -1.31 | -1.43 | -2.42 |
Net Debt / FCF Ratio | -1.86 | -1.38 | -1.36 | -2.52 | -2.86 | -4.21 |
Asset Turnover | 0.61 | 0.65 | 0.64 | 0.68 | 0.67 | 0.70 |
Inventory Turnover | 3.07 | 2.94 | 2.95 | 2.73 | 2.42 | 2.74 |
Quick Ratio | 2.05 | 1.76 | 1.41 | 1.56 | 1.79 | 2.08 |
Current Ratio | 2.67 | 2.35 | 1.87 | 1.96 | 2.48 | 2.76 |
Return on Equity (ROE) | 13.49% | 14.26% | 13.75% | 13.74% | 11.32% | 9.79% |
Return on Assets (ROA) | 5.85% | 6.33% | 5.88% | 6.46% | 5.36% | 4.95% |
Return on Invested Capital (ROIC) | 12.91% | 14.46% | 15.07% | 15.99% | 13.57% | 13.72% |
Return on Capital Employed (ROCE) | 11.00% | 12.20% | 12.90% | 12.90% | 10.20% | 9.40% |
Earnings Yield | 9.42% | 8.72% | 8.01% | 8.79% | 6.46% | 6.71% |
FCF Yield | 4.30% | 4.61% | 5.84% | 6.55% | 4.87% | 6.09% |
Dividend Yield | 2.87% | 2.62% | 2.44% | 1.44% | 3.44% | 3.97% |
Payout Ratio | 44.05% | 43.48% | 90.88% | 18.31% | 67.94% | 32.34% |
Buyback Yield / Dilution | -0.68% | -0.61% | -0.33% | 1.07% | 0.74% | 0.00% |
Total Shareholder Return | 2.16% | 2.01% | 2.11% | 2.52% | 4.18% | 3.97% |